| Tag | Content |
|---|
EnhancerAtlas ID | HS101-46178 |
Organism | Homo sapiens |
Tissue/cell | HT29 |
Coordinate | chr9:126089090-126090760 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| BHLHE41 | MA0636.1 | chr9:126089162-126089172 | GTCACGTGAC | + | 6.02 | | BHLHE41 | MA0636.1 | chr9:126089162-126089172 | GTCACGTGAC | - | 6.02 | | Foxd3 | MA0041.1 | chr9:126089422-126089434 | GTTTGTTTGTTT | + | 6.32 | | Foxd3 | MA0041.1 | chr9:126089426-126089438 | GTTTGTTTGTTT | + | 6.32 | | MITF | MA0620.2 | chr9:126089158-126089176 | TGAGGTCACGTGACAACT | + | 7.05 | | MITF | MA0620.2 | chr9:126089158-126089176 | TGAGGTCACGTGACAACT | - | 7.05 | | MIXL1 | MA0662.1 | chr9:126089850-126089860 | GTTAATTAGA | - | 6.02 | | USF1 | MA0093.2 | chr9:126089161-126089172 | GGTCACGTGAC | - | 6.14 | | USF2 | MA0526.2 | chr9:126089158-126089174 | TGAGGTCACGTGACAA | + | 6.26 |
|
| | Number of super-enhancer constituents: 11 | ID | Coordinate | Tissue/cell |
| SE_10272 | chr9:126088167-126089511 | CD19_Primary | | SE_11088 | chr9:126087725-126090674 | CD20 | | SE_27373 | chr9:126088444-126089577 | Esophagus | | SE_27373 | chr9:126089621-126091227 | Esophagus | | SE_40171 | chr9:126088501-126089484 | K562 | | SE_58675 | chr9:126066110-126112932 | Ly1 | | SE_59949 | chr9:126072819-126109309 | Ly4 | | SE_60622 | chr9:126083387-126112614 | DHL6 | | SE_61709 | chr9:126066543-126112588 | Toledo | | SE_62912 | chr9:126066502-126108695 | Tonsil | | SE_68067 | chr9:126071237-126113711 | TC32 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr9 | 126089952 | 126090200 | | chr9 | 126090200 | 126090423 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH09I123326 | chr9 | 126088319 | 126090979 |
|
Enhancer Sequence | AGCCAGTAGC TATGGCTGGA GGGTGAGGTC ATGTGCCAGC TCCTGTAACA TGAGGTCATA 60
TGGCAACATG AGGTCACGTG ACAACTGCAG GGCCCACCTG CCTAGACAGG GTGGGGAGAG 120
GAGCTGGTCT CAAAAAGGAG GAAGTGCTTT TGAGAAGGAA TGGTGTGGGG AGGGTGGGTT 180
GGCCCTCAAA CCAGTAGGGA TCTCACAAGG CCAGCGGGGT GCTTGTTGTG GAGCCTTTGG 240
GAGGCTGCAG TCCCAAGCGA TCCTTACCTT TTTGGTGCCC TCGACCCCTT TGGCATCGAG 300
TGAAGCCTGT GGACCCTTTC TCAGGATTTT TTGTTTGTTT GTTTGTTTTG TTTTTGAGAC 360
AGAGTTTTGC TCTTGCTGCC CAGGCTGGAG TGCAGTAGCA CGATCTTAGC TCACTGCAAT 420
CTCTGCCTCC CAGGTTCAAG CAATTCTCCT GCCTCAGCCT CCTGAGTAGC TGGGATTACA 480
GGCAAGCACC ACCATGCCCA GCTAATTTTT GTGTTTTTAG TAGAGACTGG GTTTCGCCAT 540
GTTGGCCAGT CTGGTCTTGA GTTCCTGACC TCAGGTGATC CACCTGCCTT GGCCTCCCAA 600
AGTGCTGGGA TTATAGGCAT GAGCCACCAC ACCAAGCCTC TCAGGATCAT ATTTTCAAAT 660
GCATCAAATA AAATATCTAG CATCGCAGAG TAAACCAATT ACATTGGTTC TGTCCACAGC 720
CCCCTTGAGG ACTCAATATT GAAGGAGTGT GAAAAGACAG GTTAATTAGA GATTTGCTCA 780
GACATCTCCT GGAGGAAGGT GGTGGGAGCC GTGGCCTTTC CCTTGAGGGT GGAAGTTGGT 840
GGACCCGTCT GGGTCTGGGG TGGCCCTGGG GAAGCTGGTA GTGAAGGGAA ATGGGAGTGG 900
GTTGACTGCT AAGACAAAGG TGACACCAGT CAGGGAGCTT GGCTGCTGGT GGCAAGCACA 960
GACTCCAGCT AACCTGAAGG AGTGGTTTGT AAAAGTATCG GACTCCAGCT AACCTGAAGG 1020
AGTGGTTTGT AAAAGTATCG GGTAGCTCAT GCAATTGACG GAGAAACTAG AGAAACAGGC 1080
TTGACGAGAA CCCAGAGAGT TAAGATCTGC CAAGCTGCCA CCTGGGAGCT GACTGCCGGC 1140
CAGCTGGTCA CTGTGGCCCC ATCTGACACC TCCAGCCATG GAGATGACGC CCACACAGCA 1200
CGAGATGTCC TTCTATGGCG GCACCCTTTA AATGGCAGAC TGACTCTGTG CCTCAATGTC 1260
ACTCTACAGA GTCCTGGGAG GGCATGTCCA GCTGGCCACA CTCTAGGCTG CACGTCCATA 1320
TTCTAGTCAC TGGAAGCACA GAAGATCTGT CCCAGGCAGC TTCTGTGGGG AGAGGCGGGG 1380
GGGGGTCCTT CCACTATCTT GGGATTCTCC TAATAGATGC TGGTCAACCA AAGGGGTGAA 1440
TGTCTGATGG CTGGTTCTGA GGTGTGTGTG TATGTATACA CAGAGAATAT GTGTGTATGT 1500
GTACATCGGG CCATGTGTCA TGGCTCACGC CTATAATCCA AGCCAGGAGT TCAAGACCAG 1560
CCTGGGCAAT ATGGTGAAAT CCCATTTCTA CTAAAAATAC AAAAATTAGG TGTGGTGGTA 1620
CATGCTTGTA ATCCCAGCTA CTTGGGTGCT GAGGCATGAG AATTGCTTGA 1670
|
